These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30269480)

  • 1. Label-Free and Real-Time Detection of Tuberculosis in Human Urine Samples Using a Nanophotonic Point-of-Care Platform.
    Ramirez-Priego P; Martens D; Elamin AA; Soetaert P; Van Roy W; Vos R; Anton B; Bockstaele R; Becker H; Singh M; Bienstman P; Lechuga LM
    ACS Sens; 2018 Oct; 3(10):2079-2086. PubMed ID: 30269480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
    Sigal GB; Pinter A; Lowary TL; Kawasaki M; Li A; Mathew A; Tsionsky M; Zheng RB; Plisova T; Shen K; Katsuragi K; Choudhary A; Honnen WJ; Nahid P; Denkinger CM; Broger T
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    AIDS; 2012 Aug; 26(13):1635-43. PubMed ID: 22555166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.
    Lawn SD
    BMC Infect Dis; 2012 Apr; 12():103. PubMed ID: 22536883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive Urine Immunoassay for Visualization of Lipoarabinomannan for Noninvasive Tuberculosis Diagnosis.
    Chen P; Meng Y; Liu T; Peng W; Gao Y; He Y; Qu R; Zhang C; Hu W; Ying B
    ACS Nano; 2023 Apr; 17(7):6998-7006. PubMed ID: 37010068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine.
    Hamasur B; Bruchfeld J; Haile M; Pawlowski A; Bjorvatn B; Källenius G; Svenson SB
    J Microbiol Methods; 2001 May; 45(1):41-52. PubMed ID: 11295196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes.
    Magni R; Rruga F; Alsaab FM; Sharif S; Howard M; Espina V; Kim B; Lepene B; Lee G; Alayouni MA; Steinberg H; Araujo R; Kashanchi F; Riccardi F; Morreira S; Araujo A; Poli F; Jaganath D; Semitala FC; Worodria W; Andama A; Choudhary A; Honnen WJ; Petricoin EF; Cattamanchi A; Colombatti R; de Waard JH; Oberhelman R; Pinter A; Gilman RH; Liotta LA; Luchini A
    Sci Rep; 2020 Aug; 10(1):13944. PubMed ID: 32811861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of lipoarabinomannan antigen in tuberculosis diagnostics: current evidence.
    Sarkar P; Biswas D; Sindhwani G; Rawat J; Kotwal A; Kakati B
    Postgrad Med J; 2014 Mar; 90(1061):155-63. PubMed ID: 24429376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients.
    Broger T; Tsionksy M; Mathew A; Lowary TL; Pinter A; Plisova T; Bartlett D; Barbero S; Denkinger CM; Moreau E; Katsuragi K; Kawasaki M; Nahid P; Sigal GB
    PLoS One; 2019; 14(4):e0215443. PubMed ID: 30998715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive urinary lipoarabinomannan test for tuberculosis.
    Hamasur B; Bruchfeld J; van Helden P; Källenius G; Svenson S
    PLoS One; 2015; 10(4):e0123457. PubMed ID: 25905641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
    Peter JG; Zijenah LS; Chanda D; Clowes P; Lesosky M; Gina P; Mehta N; Calligaro G; Lombard CJ; Kadzirange G; Bandason T; Chansa A; Liusha N; Mangu C; Mtafya B; Msila H; Rachow A; Hoelscher M; Mwaba P; Theron G; Dheda K
    Lancet; 2016 Mar; 387(10024):1187-97. PubMed ID: 26970721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of point-of-care urinary lipoarabinomannan testing for the diagnosis of tuberculosis in critically ill patients: a prospective observational study.
    de Vasconcellos K; Ramjathan P; Singh D
    BMC Infect Dis; 2021 Mar; 21(1):281. PubMed ID: 33740905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plastic-Chip-Based Magnetophoretic Immunoassay for Point-of-Care Diagnosis of Tuberculosis.
    Kim J; Jang M; Lee KG; Lee KS; Lee SJ; Ro KW; Kang IS; Jeong BD; Park TJ; Kim HJ; Lee J
    ACS Appl Mater Interfaces; 2016 Sep; 8(36):23489-97. PubMed ID: 27548010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of Mycobacterium tuberculosis biomarkers in a sandwich immunoassay format using a waveguide-based optical biosensor.
    Mukundan H; Kumar S; Price DN; Ray SM; Lee YJ; Min S; Eum S; Kubicek-Sutherland J; Resnick JM; Grace WK; Anderson AS; Hwang SH; Cho SN; Via LE; Barry C; Sakamuri R; Swanson BI
    Tuberculosis (Edinb); 2012 Sep; 92(5):407-16. PubMed ID: 22710249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine.
    De P; Amin AG; Valli E; Perkins MD; McNeil M; Chatterjee D
    PLoS One; 2015; 10(12):e0144088. PubMed ID: 26633829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyanobacterial lectin, microvirin-N, enhances the specificity and sensitivity of lipoarabinomannan-based TB diagnostic tests.
    van der Horst M; Karamchand L; Bauer WS; Nel AJM; Blackburn JM; Wright DW
    Analyst; 2021 Feb; 146(4):1207-1215. PubMed ID: 33367346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
    Thit SS; Aung NM; Htet ZW; Boyd MA; Saw HA; Anstey NM; Kyi TT; Cooper DA; Kyi MM; Hanson J
    BMC Med; 2017 Aug; 15(1):145. PubMed ID: 28774293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.
    Zijenah LS; Kadzirange G; Bandason T; Chipiti MM; Gwambiwa B; Makoga F; Chungu P; Kaguru P; Dheda K
    BMC Infect Dis; 2016 Jan; 16():20. PubMed ID: 26797499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.